Success Metrics

Active Trials
1(17%)

Phase Distribution

Ph phase_4
2
33%
Ph phase_2
2
33%
Ph not_applicable
1
17%
Ph phase_1
1
17%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(6)

Detailed Status

Not yet recruiting5
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 42 (33.3%)
N/A1 (16.7%)

Trials by Status

recruiting117%
not_yet_recruiting583%

Recent Activity

1 active trials
Showing 5 of 6
not_yet_recruitingphase_4

Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis

NCT07451665
not_yet_recruitingphase_4

Efficacy and Safety of Ivarmacitinib Monotherapy in the Treatment of csDMARDs-IR Rheumatoid Arthritis

NCT07452445
not_yet_recruitingphase_1

A Clinical Study on the Efficacy and Safety of Ivarmacitinib in Preventing aGVHD After HLA-matched Transplantation

NCT07381114
not_yet_recruitingphase_2

Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance

NCT07313202
recruitingnot_applicable

A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis

NCT07270003
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07451665Phase 4

Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis

Not Yet Recruiting
NCT07452445Phase 4

Efficacy and Safety of Ivarmacitinib Monotherapy in the Treatment of csDMARDs-IR Rheumatoid Arthritis

Not Yet Recruiting
NCT07381114Phase 1

A Clinical Study on the Efficacy and Safety of Ivarmacitinib in Preventing aGVHD After HLA-matched Transplantation

Not Yet Recruiting
NCT07313202Phase 2

Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance

Not Yet Recruiting
NCT07270003Not Applicable

A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis

Recruiting
NCT06731153Phase 2

JAK1 Inhibitor Ivarmacitinib Reversing Immunotherapy Resistance in TNBC

Not Yet Recruiting

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6